A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment
Aim: To elicit patients’ preferences for HIV/AIDS treatment characteristics in Colombia. Materials and methods: A best–worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, participan...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2018
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22393
- Acceso en línea:
- https://doi.org/10.1080/13696998.2018.1440401
https://repository.urosario.edu.co/handle/10336/22393
- Palabra clave:
- Antiretrovirus agent
Antiretrovirus agent
Acquired immune deficiency syndrome
Adult
Alcohol consumption
Antiretroviral therapy
Article
Best worst scaling
Clinical assessment
Clinical effectiveness
Colombian
Comorbidity
Diagnostic test
Disease duration
Domestic violence
Female
Heterosexuality
Homosexuality
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
Life expectancy
Major clinical study
Male
Methodology
Self concept
Sexual education
Sexuality
Social behavior
Treatment duration
Acquired immune deficiency syndrome
Age
Bayes theorem
Colombia
Decision making
Drug administration
Educational status
Health behavior
Human immunodeficiency virus infection
Middle aged
Patient preference
Severity of illness index
Sex factor
Socioeconomics
Acquired immunodeficiency syndrome
Adult
Age factors
Anti-retroviral agents
Bayes theorem
Choice behavior
Colombia
Decision making
Drug administration schedule
Educational status
Health behavior
Hiv infections
Humans
Life expectancy
Male
Middle aged
Patient preference
Severity of illness index
Sex factors
Socioeconomic factors
Aids
Best-worst scaling
Hiv
Patient preferences
Transferability
Treatment
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_c9555aff40408dc21698fcad71429652 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/22393 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
d518dd69-192e-4730-9ed2-c263d1684828d27de9a1-69ed-4f0f-81a2-60ba435836d30a1d62d9-de1a-410d-92a7-4129dd6d64726841b6b8-d7f2-41fd-a4d8-e017407b0d6c67b1beef-72e7-489e-afca-c28f8d2f048a6758056600f3063591-dc50-4b3a-a1db-7f6ef4aed081522eaf90-589d-4808-8bb9-328af2698c102f4b23a2-ead8-4ee3-ab1e-1eca7b2703592020-05-25T23:56:19Z2020-05-25T23:56:19Z2018Aim: To elicit patients’ preferences for HIV/AIDS treatment characteristics in Colombia. Materials and methods: A best–worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, participants were asked to choose the most important and the least important treatment characteristics from a set of five from the master list. Using the Hierarchical Bayes method, relative importance scores were calculated. Sub-group analyses were conducted according to sex, education, source of infection, symptoms, and age. Results: A total of 195 patients fully completed the questionnaire. The three most important characteristics were “drug has very high efficacy” (relative importance score [RIS] = 10.1), “maximum prolongation of life expectancy” (RIS = 9.7), and “long duration of efficacy” (RIS = 7.4). Sub-group analysis showed only three significant (but minor) differences between older and younger people. Conclusion: This study suggests that treatment characteristics regarding efficacy and prolongation of life are particularly important for patients in Colombia. Further investigation on how patients make trade-offs between these important characteristics and incorporating this information in clinical and policy decision-making would be needed to improve adherence with HIV/AIDS medication. © 2018 Informa UK Limited, trading as Taylor and Francis Group.application/pdfhttps://doi.org/10.1080/13696998.2018.144040113696998https://repository.urosario.edu.co/handle/10336/22393engTaylor and Francis Ltd473No. 5468Journal of Medical EconomicsVol. 21Journal of Medical Economics, ISSN:13696998, Vol.21, No.5 (2018); pp. 468-473https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042927545&doi=10.1080%2f13696998.2018.1440401&partnerID=40&md5=e2c2c0cde953abf203e2e967ceda321dAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAntiretrovirus agentAntiretrovirus agentAcquired immune deficiency syndromeAdultAlcohol consumptionAntiretroviral therapyArticleBest worst scalingClinical assessmentClinical effectivenessColombianComorbidityDiagnostic testDisease durationDomestic violenceFemaleHeterosexualityHomosexualityHumanHuman immunodeficiency virus infected patientHuman immunodeficiency virus infectionLife expectancyMajor clinical studyMaleMethodologySelf conceptSexual educationSexualitySocial behaviorTreatment durationAcquired immune deficiency syndromeAgeBayes theoremColombiaDecision makingDrug administrationEducational statusHealth behaviorHuman immunodeficiency virus infectionMiddle agedPatient preferenceSeverity of illness indexSex factorSocioeconomicsAcquired immunodeficiency syndromeAdultAge factorsAnti-retroviral agentsBayes theoremChoice behaviorColombiaDecision makingDrug administration scheduleEducational statusHealth behaviorHiv infectionsHumansLife expectancyMaleMiddle agedPatient preferenceSeverity of illness indexSex factorsSocioeconomic factorsAidsBest-worst scalingHivPatient preferencesTransferabilityTreatmentA best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatmentarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Hendriks A.Wijnen B.van Engelen R.Conde R.Evers S.M.González Rodríguez, Javier LeonardoGovers M.Mühlbacher A.Hiligsmann M.10336/22393oai:repository.urosario.edu.co:10336/223932022-05-02 07:37:16.20158https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
title |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
spellingShingle |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment Antiretrovirus agent Antiretrovirus agent Acquired immune deficiency syndrome Adult Alcohol consumption Antiretroviral therapy Article Best worst scaling Clinical assessment Clinical effectiveness Colombian Comorbidity Diagnostic test Disease duration Domestic violence Female Heterosexuality Homosexuality Human Human immunodeficiency virus infected patient Human immunodeficiency virus infection Life expectancy Major clinical study Male Methodology Self concept Sexual education Sexuality Social behavior Treatment duration Acquired immune deficiency syndrome Age Bayes theorem Colombia Decision making Drug administration Educational status Health behavior Human immunodeficiency virus infection Middle aged Patient preference Severity of illness index Sex factor Socioeconomics Acquired immunodeficiency syndrome Adult Age factors Anti-retroviral agents Bayes theorem Choice behavior Colombia Decision making Drug administration schedule Educational status Health behavior Hiv infections Humans Life expectancy Male Middle aged Patient preference Severity of illness index Sex factors Socioeconomic factors Aids Best-worst scaling Hiv Patient preferences Transferability Treatment |
title_short |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
title_full |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
title_fullStr |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
title_full_unstemmed |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
title_sort |
A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment |
dc.subject.keyword.spa.fl_str_mv |
Antiretrovirus agent Antiretrovirus agent Acquired immune deficiency syndrome Adult Alcohol consumption Antiretroviral therapy Article Best worst scaling Clinical assessment Clinical effectiveness Colombian Comorbidity Diagnostic test Disease duration Domestic violence Female Heterosexuality Homosexuality Human Human immunodeficiency virus infected patient Human immunodeficiency virus infection Life expectancy Major clinical study Male Methodology Self concept Sexual education Sexuality Social behavior Treatment duration Acquired immune deficiency syndrome Age Bayes theorem Colombia Decision making Drug administration Educational status Health behavior Human immunodeficiency virus infection Middle aged Patient preference Severity of illness index Sex factor Socioeconomics Acquired immunodeficiency syndrome Adult Age factors Anti-retroviral agents Bayes theorem Choice behavior Colombia Decision making Drug administration schedule Educational status Health behavior Hiv infections Humans Life expectancy Male Middle aged Patient preference Severity of illness index Sex factors Socioeconomic factors Aids Best-worst scaling Hiv Patient preferences Transferability Treatment |
topic |
Antiretrovirus agent Antiretrovirus agent Acquired immune deficiency syndrome Adult Alcohol consumption Antiretroviral therapy Article Best worst scaling Clinical assessment Clinical effectiveness Colombian Comorbidity Diagnostic test Disease duration Domestic violence Female Heterosexuality Homosexuality Human Human immunodeficiency virus infected patient Human immunodeficiency virus infection Life expectancy Major clinical study Male Methodology Self concept Sexual education Sexuality Social behavior Treatment duration Acquired immune deficiency syndrome Age Bayes theorem Colombia Decision making Drug administration Educational status Health behavior Human immunodeficiency virus infection Middle aged Patient preference Severity of illness index Sex factor Socioeconomics Acquired immunodeficiency syndrome Adult Age factors Anti-retroviral agents Bayes theorem Choice behavior Colombia Decision making Drug administration schedule Educational status Health behavior Hiv infections Humans Life expectancy Male Middle aged Patient preference Severity of illness index Sex factors Socioeconomic factors Aids Best-worst scaling Hiv Patient preferences Transferability Treatment |
description |
Aim: To elicit patients’ preferences for HIV/AIDS treatment characteristics in Colombia. Materials and methods: A best–worst scaling case was used to provide a ranking of 26 HIV/AIDS treatment characteristics that were similar to a previous study conducted in Germany. In each choice task, participants were asked to choose the most important and the least important treatment characteristics from a set of five from the master list. Using the Hierarchical Bayes method, relative importance scores were calculated. Sub-group analyses were conducted according to sex, education, source of infection, symptoms, and age. Results: A total of 195 patients fully completed the questionnaire. The three most important characteristics were “drug has very high efficacy” (relative importance score [RIS] = 10.1), “maximum prolongation of life expectancy” (RIS = 9.7), and “long duration of efficacy” (RIS = 7.4). Sub-group analysis showed only three significant (but minor) differences between older and younger people. Conclusion: This study suggests that treatment characteristics regarding efficacy and prolongation of life are particularly important for patients in Colombia. Further investigation on how patients make trade-offs between these important characteristics and incorporating this information in clinical and policy decision-making would be needed to improve adherence with HIV/AIDS medication. © 2018 Informa UK Limited, trading as Taylor and Francis Group. |
publishDate |
2018 |
dc.date.created.spa.fl_str_mv |
2018 |
dc.date.accessioned.none.fl_str_mv |
2020-05-25T23:56:19Z |
dc.date.available.none.fl_str_mv |
2020-05-25T23:56:19Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1080/13696998.2018.1440401 |
dc.identifier.issn.none.fl_str_mv |
13696998 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/22393 |
url |
https://doi.org/10.1080/13696998.2018.1440401 https://repository.urosario.edu.co/handle/10336/22393 |
identifier_str_mv |
13696998 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
473 |
dc.relation.citationIssue.none.fl_str_mv |
No. 5 |
dc.relation.citationStartPage.none.fl_str_mv |
468 |
dc.relation.citationTitle.none.fl_str_mv |
Journal of Medical Economics |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 21 |
dc.relation.ispartof.spa.fl_str_mv |
Journal of Medical Economics, ISSN:13696998, Vol.21, No.5 (2018); pp. 468-473 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042927545&doi=10.1080%2f13696998.2018.1440401&partnerID=40&md5=e2c2c0cde953abf203e2e967ceda321d |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Taylor and Francis Ltd |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167655511228416 |